BIOLIFE4D Hopes to Raise $50M to Develop 3D Printed Transplantable Hearts

BIOLIFE4D Hopes to Raise $50M to Develop 3D Printed Transplantable Hearts

“Each year, worldwide, approximately 5,000 heart transplant procedures are undertaken, about 2,500 of those in the United States. However, in the neighborhood of 4,000 people each year are awaiting heart transplants in the US and the majority of those who do not receive the needed transplant continue to wait because of a lack of available donor organs. Having made great advances in the procedure and in the medications to suppress rejection, the biggest roadblock to increasing the number of successful heart transplants is simply the number of hearts. For this reason, great hopes have been associated with the development of 3D bioprinting capabilities that one they, one day, might lead to the ability to produce the organs directly, thereby eliminating the difficulties associated with the restriction of their supply.

While this is held as a pipe dream by some, BIOLIFE4D is looking to tackle this issue head on and in order to do so, they need to gather the funding necessary for such an undertaking. As a result, they have determined that the time is ripe to launch a Regulation A+ (Mini-IPO) offering with the hopes of raising $50 million, a plan they have been working toward. As the CEO of BIOLIFE4D, Steven Morris, explained at the opening of the offering…”

#future = #REALnews #health #medicine #medtech #wellness #tech #innovation #science #design #biotech #biology #xMed #singularity #engineering #ai #artificialintelligence #robots #automation #3dprinting

https://3dprint.com/202314/biolife4d-transplantable-hearts/

https://3dprint.com/202314/biolife4d-transplantable-hearts/